The Philadelphia Department of Public Health has a long history of participating in research to improve services and care for the good of the public. As required by Department policy, medical ethics and federal regulations, all research that involves human subjects must be reviewed by an Institutional Review Board (IRB) prior to implementation and on an ongoing basis.
- Philadelphia Department of Behavioral Health
- Philadelphia Department of Human Services (with limited exclusions, please ask for guidance)
- Philadelphia Department of Public Health
- Philadelphia Office of Supportive Housing
- Prison Health Services
- involving data, staff, or specimens from the Medical Examiner's Office, or
- submitted with a request for review by other City departments.
- Philadelphia Department of Public Health data
- Persons receiving services directly from or funded by/through the Department
- Proposals for research that will result in publication and/or conference presentation
Studies must include an investigator or collaborator working for Philadelphia Department of Public Health.
Health Commissioner’s Office Review Committee
- the Principal Investigator/CO-PI (applicant) works at a non-City entity,
- the Principal Investigator/CO-PI (applicant) will share/transmit City data to any non-City entity,
- the Principal Investigator/CO-PI (applicant) intends to publish the results of the study.
DLAs must be approved by the Philadelphia Law Department. Applicants should contact Assistant City Solicitor Benjamin Mishkin (email@example.com) for more information.
Applicants should be prepared to provide the following documentation: 1) their IRB application materials, 2) the IRB’s approval or waiver letter, 3) a list of all data points/variables sought, 4) a narrative description of the study (if not included with the IRB application materials), 5) a letter of support from the data-contributing City Department, and 6) any state- or federal-level approvals, if necessary.
Information and forms:
- The Belmont Report
- NIH Human Subjects Training
- Office for Human Research Protection, HHS
- Clinical Trials and Human Subject Protection, FDA